Trademark: 97312047
Word
BOOSTER THERAPEUTICS
Status
Pending
Status Code
654
Status Date
Wednesday, January 3, 2024
Serial Number
97312047
Mark Type
4000
Filing Date
Monday, March 14, 2022

Trademark Owner History

Classifications
5 Pharmaceutical preparations for the treatment of the pathologies of aging, neurodegenerative diseases, brain diseases, ocular diseases, skin disorders and skin conditions, kidney diseases, liver diseases , heart diseases, urology disorders, circulatory disorders, muscle diseases, pancreas diseases, digestive system diseases, lung diseases, memory loss, fatigue, eye strain, eye disease, hearing loss, hair loss, sexual disfunction and reproductive system diseases; Compound drugs and pharmaceuticals for the use in the field of oncology, immunology, inflammatory diseases, and central nervous system disorders to treat the pathologies of aging, neurodegenerative diseases, brain diseases, ocular diseases, skin disorders and skin conditions, kidney diseases, liver diseases , heart diseases, urology disorders, circulatory disorders, muscle diseases, pancreas diseases, digestive system diseases, lung diseases, memory loss, fatigue, eye strain, eye disease, hearing loss, hair loss, sexual disfunction and reproductive system diseases, by degrading disease-causing cellular proteins; Compound drugs and pharmaceuticals for the treatment of the pathologies of aging, neurodegenerative diseases, brain diseases, ocular diseases, skin disorders and skin conditions, kidney diseases, liver diseases , heart diseases, urology disorders, circulatory disorders, muscle diseases, pancreas diseases, digestive system diseases, lung diseases, memory loss, fatigue, eye strain, eye disease, hearing loss, hair loss, sexual disfunction and reproductive system diseases, by degrading disease-causing cellular proteins; Biological reagents for medical use; Cellular function activating agents for medical purposes; Chemical reagents for medical use; Clinical diagnostic reagents; Diagnostic testing materials for medical use, namely, Diagnostic reagents for medicinal use; Diagnostic substances for medical use; Disinfectants and antiseptics; Drug delivery agents, namely, Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Arsenic, Benzol and Chlorine detoxification agents for medical purposes; Drugs being pharmaceuticals, medical and veterinary preparations for the treatment of for the treatment of the pathologies of aging, neurodegenerative diseases, brain diseases, ocular diseases, skin disorders and skin conditions, kidney diseases, liver diseases , heart diseases, urology disorders, circulatory disorders, muscle diseases, pancreas diseases, digestive system diseases, lung diseases, memory loss, fatigue, eye strain, eye disease, hearing loss, hair loss, sexual disfunction and reproductive system diseases, caused by degrading disease-causing cellular proteins; Enzymes for medical purposes; General anaesthetics; Pharmaceuticals, medical and veterinary preparations for the treatment of for the treatment of the pathologies of aging, neurodegenerative diseases, brain diseases, ocular diseases, skin disorders and skin conditions, kidney diseases, liver diseases , heart diseases, urology disorders, circulatory disorders, muscle diseases, pancreas diseases, digestive system diseases, lung diseases, memory loss, fatigue, eye strain, eye disease, hearing loss, hair loss, sexual disfunction and reproductive system diseases, caused by degrading disease-causing cellular proteins; Sanitary preparations for medical purposes; Food for babies; Dietary supplements for human beings and animals; Sticking plasters for medical purposes; Materials for medical and surgical dressings; Material for stopping teeth; Dental wax; Disinfectants; Preparations for destroying vermin; Fungicides; Herbicides
42 Medical laboratory services; Biological research; Clinical research in the field the pathologies of aging, neurodegenerative diseases, brain diseases, ocular diseases, skin disorders and skin conditions, kidney diseases, liver diseases , heart diseases, urology disorders, circulatory disorders, muscle diseases, pancreas diseases, digestive system diseases, lung diseases, memory loss, fatigue, eye strain, eye disease, hearing loss, hair loss, sexual disfunction and reproductive system diseases, by degrading disease-causing cellular proteins; Medical research; Scientific research in the nature of conducting clinical trials for others in the field of pharmaceutical products; Research and development for the pharmaceutical industry; Consultancy relating to pharmaceutical research and development; Scientific and technological services, namely, scientific research, analysis and testing research in the field the pathologies of aging, neurodegenerative diseases, brain diseases, ocular diseases, skin disorders and skin conditions, kidney diseases, liver diseases , heart diseases, urology disorders, circulatory disorders, muscle diseases, pancreas diseases, digestive system diseases, lung diseases, memory loss, fatigue, eye strain, eye disease, hearing loss, hair loss, sexual disfunction and reproductive system diseases, by degrading disease-causing cellular proteins, and scientific research and Design of computer software relating thereto; Application service provider, namely, Providing online non-downloadable computer software platforms for medical research in the field of drug discovery and drug development; Programming of a drug discovery and development computer software platform for others; Online electronic data storage; Consultancy and assistance services in the nature of website design consultancy and computer software consulting, via an online website and data network platform, in the field of medical sciences including cell metabolism, aging and cell health; Computer services, namely, hosting of an online platform in the nature of online web facilities for the archiving, evaluation, analysation and exchange of data in the fields of biological research, clinical research and medical research

Trademark Events
Jan 3, 2024
Report Completed Suspension Check Case Still Suspended
May 2, 2023
Notification Of Letter Of Suspension E-Mailed
May 2, 2023
Letter Of Suspension E-Mailed
May 2, 2023
Suspension Letter Written
Apr 4, 2023
Teas/Email Correspondence Entered
Apr 3, 2023
Correspondence Received In Law Office
Apr 3, 2023
Teas Response To Office Action Received
Jan 3, 2023
Notification Of Non-Final Action E-Mailed
Jan 3, 2023
Non-Final Action E-Mailed
Jan 3, 2023
Non-Final Action Written
Dec 23, 2022
Assigned To Examiner
Mar 18, 2022
New Application Office Supplied Data Entered
Mar 17, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24